Skip to main content
. 2019;20(7):2051–2057. doi: 10.31557/APJCP.2019.20.7.2051

Table 3.

Univariate Analysis of Factor that Affected Laryngeal Preservation

Variables Median survival mo.) P-value
Group stage III
IV
21.9 (0.35,43.44)
5.4 (1.05,9.74)
0.046
Volume <10ml
>=10ml
unknown
35.4 (5.14,65.65)
1.3 (0.35,2.25)
0.005
Cord
Involvement
No
Unilateral
Bilateral
15.5 (0.90,30.09)
11.7 (6.60,16.79)
0.5
0.016
N stage N0
N1
N2
N3
12.3 (6.50,18.09)
16.9 (0-36.25)
Not reach
1.3 (0.92,1.68)
0.008
Dose 45-50 Gy
51-60 Gy
61-70 Gy
2.3 (0.34,4.26)
0.5
19.2 (7.63,30.77)
<0.001
Treatment
Break
None
≤ 1 wk
>1-2 wk
12.3 (2.71,21.88)
11 (0,23.16)
1.1
0.017